The more prospective healthy donors we can identify as early as possible, the sooner we may be able to initiate development of this potential treatment and the more therapies we can potentially provide.
If you are interested learning more — without obligation — please contact the BioLife MedInfo Center by completing the form below.
BioLife Plasma Services, part of Takeda, has implemented a unique protocol for collecting plasma from healthy individuals who have recovered from COVID-19 to enable development of a potential therapy for COVID-19, made from human plasma. You can read more about this here.
For a list of Donation Centers, click here.
The more prospective healthy donors we can identify as early as possible, the sooner we may be able to initiate development of this potential treatment and the more therapies we can potentially provide. With the SARS-CoV-2 virus continuing to spread and cases of COVID-19 continuing to rise worldwide, we count on the support of those who have fully recovered to help us with our efforts to develop a potential treatment for those most at risk.
